Skip to main content
Log in

Preoperative chemoradiation treatment strategies for localized sarcoma

  • Educational Review
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Over the past 2 decades, there has been increasing interest in chemoradiation treatment strategies for patients with soft tissue sarcomas. Investigators have evaluated: (1) the optimal route for chemotherapy administration (intra-arterial vs. intravenous); (2) the possible advantages of protracted infusion of the radiosensitizer versus brief infusion; (3) the efficacy and toxicity of various intravenous and oral radiation sensitizers; and (4) the efficacy of sequential versus concurrent combined modality treatment.

Methods

The English-language literature addressing chemoradiation for localized and locally advanced extremity and retroperitoneal sarcomas was reviewed.

Results

All studies have been pilot, phase I, or phase II designs. The most commonly used radiosensitizer for concurrent chemoradiation has been doxorubicin, administered intravenously in most recent reports. In the studies that have included assessment of recurrence-free survival, preoperative chemoradiation combined with surgery has resulted in favorable local control rates, often in excess of 90% for patients with localized and locally advanced extremity sarcomas.

Conclusions

The toxicities and recurrence-free outcome with chemoradiation plus surgery for soft tissue sarcoma still need to be compared to these with surgery and pre- or postoperative radiation. However, the generally favorable local control rates reported for chemoradiation justify continued investigation of preoperative chemoradiation strategies for localized sarcoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Eilber FR, Giuliano AE, Huth JH, Mirra JJ, Rosen G, Morton DL. Neoadjuvant chemotherapy, radiation, and limited surgery for high grade soft tissue sarcoma of the extremity. In: Ryan JR, Baker LO, eds.Recent Concepts in Sarcoma Treatment. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1988:115–22.

    Google Scholar 

  2. Eilber FR, Giuliano AE, Huth JF, Weisenburger TH, Eckardt J. Intravenous (IV) vs. intraarterial (IA) Adriamycin, 2800r radiation and surgical excision for extremity soft tissue sarcomas: a randomized prospective trial [Abstract].Proc Am Soc Clin Oncol 1990;9:309.

    Google Scholar 

  3. Karakousis CP, Emrich LJ, Rao UN, Krishnamsetty RM. Feasibility of limb salvage and survival in soft tissue sarcomas.Cancer 1986;57:484–91.

    Article  PubMed  CAS  Google Scholar 

  4. Goodnight JEJ, Bargar WL, Voegeli T, Blaisdell FW. Limbsparing surgery for extremity sarcomas after preoperative intraarterial doxorubicin and radiation therapy.Am J Surg 1985;150:109–13.

    Article  PubMed  Google Scholar 

  5. Levine EA, Trippon M, DasGupta TK. Preoperative multimodality treatment for soft tissue sarcomas.Cancer 1993;71:3685–9.

    Article  PubMed  CAS  Google Scholar 

  6. Wanebo HJ, Temple WJ, Popp MB, Constable W, Aron B, Cunningham SL. Preoperative regional therapy for extremity sarcoma. A tricenter update.Cancer 1995;75:2299–306.

    Article  PubMed  CAS  Google Scholar 

  7. Temple WJ, Temple CLF, Arthur K, Schachar NS, Paterson AHG, Crabtree TS. Prospective cohort study of neoadjuvant treatment in conservative surgery of soft tissue sarcomas.Ann Surg Oncol 1997;4:586–90.

    Article  PubMed  CAS  Google Scholar 

  8. Rich TA, Janjan NA, Abbruzzese JL, Evans DB. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas (response).J Clin Oncol 1997;15:3292–3.

    Google Scholar 

  9. Cox JD. Time, dose and fractionation in radiation therapy: an historical perspective.Front Radiat Ther Oncol 1988;22:14–8.

    PubMed  CAS  Google Scholar 

  10. Toma S, Palumbo R, Vincente M, et al. Concomitant doxorubicin (DOXO) by continuous infusion (CI) and radiotherapy (RT) at low doses in locally advanced and/or metastatic soft tissue sarcomas (STS): long-term results of a phase II study [Abstract].Proc Am Soc Clin Oncol 1995;14:520.

    Google Scholar 

  11. Pisters PWT, Brennan MF. Sarcomas of soft tissue. In: Abeloff M, Armitage J, Lichter A, Niederhuber J, eds.Clinical Oncology. New York: Churchill Livingstone, 2000:2273–313.

    Google Scholar 

  12. Brennan MF, Alektiar K, Maki RG. Soft tissue sarcoma. In: DeVita VT Jr, Hellman S, Rosenberg SA, edsCancer: Principles and Practice of Oncology, Philadelphia: JB Lippincott Co., 2001: 1841–90.

    Google Scholar 

  13. Patel SR, Vadhan-Raj S, Burgess MA, et al. Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas.Am J Clin Oncol 1998;21:317–21.

    Article  PubMed  CAS  Google Scholar 

  14. Reichardt P, Tilgner J, Hohenberger P, Dorken B. Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: a phase II study.J Clin Oncol 1998;16:1438–43.

    PubMed  CAS  Google Scholar 

  15. Kraybill WG, Spiro IJ, Harris JA, et al. Radiation Therapy Oncology Group (RTOG) 95-14: a phase II study of neoadjuvant themotherapy (CT) and radiation therapy (RT) in high risk (HR), high grade, soft tissue sarcomas (STS) of the extremities and body wall: a preliminary report [Abstract].Proc Am Soc Clin Oncol 2001;20: 348a.

    Google Scholar 

  16. Spiro IJ, Suit HD, Gebhardt MC, et al. Neoadjuvant chemotherapy and radiotherapy for large soft tissue sarcomas [Abstract].Proc Am Soc Clin Oncol 1996;15:524.

    Google Scholar 

  17. Epstein AH, Lebovics RS, Goffman T, et al. Treatment of locally advanced cancer of the head and neck with 5′-iododeoxyuridine and hyperfractionated radiation therapy: measurement of cell labeling and thymidine replacement.J Natl Cancer Inst 1994;86: 1775–80.

    Article  PubMed  CAS  Google Scholar 

  18. Urtasun RC, Kinsella TJ, Farnan N, DelRowe JD, Lester SG, Fulton DS. Survival improvement in anaplastic astrocytoma, combining external radiation with halogenated pyrimidines: final report of RTOG 86-12, Phase I–II study [see comments].Int J Radiat Oncol Biol Phys 1996;36:1163–7.

    Article  PubMed  CAS  Google Scholar 

  19. Goffman T, Tochner Z, Glatstein EJ. Primary treatment of large and massive adult sarcomas with iododeoxyuridine and aggressive hyperfractionated irradiation.Cancer 1991;67:572–6.

    Article  PubMed  CAS  Google Scholar 

  20. Sondak VK, Robertson JM, Sussman JJ, Saran PA, Chang AE, Lawrence TS. Preoperative idoxuridine and radiation for large soft tissue sarcomas: clinical results with five-year follow-up.Ann Surg Oncol 1998;5:106–12.

    Article  PubMed  CAS  Google Scholar 

  21. Hellmann K, Rhomberg W. Radiotherapeutic enhancement by razoxane (review).Cancer Treat Rev 1991;18:225–40.

    Article  PubMed  CAS  Google Scholar 

  22. Rhomberg W, Hassenstein EO, Gefeller D. Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas: final results of a randomized study.Int J Radiat Oncol Biol Phys 1996;36:1077–84.

    Article  PubMed  CAS  Google Scholar 

  23. Arndt CA, Nascimento AG, Schroeder G, et al. Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide.Eur J Cancer 1998;34:1224–9.

    Article  PubMed  CAS  Google Scholar 

  24. Habrand JL, Gerbaulet A, Pejovic MH, et al. Twenty years experience of interstitial iridium brachytherapy in the management of soft tissue sarcomas.Int J Radiat Oncol Biol Phys 1991;20:405–11.

    PubMed  CAS  Google Scholar 

  25. Sauer R, Schuchardt U, Hohenberger W, et al. Neoadjuvant radiochemotherapy in soft tissue sarcomas. Optimization of local functional tumor control.Strahlenther Onkol 1999;175:259–66.

    PubMed  CAS  Google Scholar 

  26. Rosito P, Mancini AF, Rondelli R, et al. Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience.Cancer 1999;86:421–8.

    Article  PubMed  CAS  Google Scholar 

  27. Flamant F, Rodary C, Rey A, et al. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.Eur J Cancer 1998;34:1050–62.

    Article  PubMed  CAS  Google Scholar 

  28. Arndt C, Tefft M, Gehan E, et al. A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study.J Pediatr Hematol Oncol 1997;19:124–9.

    Article  PubMed  CAS  Google Scholar 

  29. Cormier JN, Patel SR, Herzog CE, et al. Concurrent ifosfamide-based chemotherapy and irradiation.Cancer 2001;92:1550–5.

    Article  PubMed  CAS  Google Scholar 

  30. Lewis JJ, Leung DHY, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution.Ann Surg 1998;228:355–65.

    Article  PubMed  CAS  Google Scholar 

  31. Pisters PWT, Harrison LB, Leung DHY, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma.J Clin Oncol 1996;14:859–68.

    PubMed  CAS  Google Scholar 

  32. Yang JC, Chang AE, Baker AR, et al. A randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.J Clin Oncol 1998;16: 197–203.

    PubMed  CAS  Google Scholar 

  33. Gieschen HL, Spiro IJ, Suit HD, et al. Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma.Int J Radiat Oncol Biol Phys 2001;50:127–31.

    Article  PubMed  CAS  Google Scholar 

  34. Jones JJ, Catton CN, O’Sullivan B, et al. Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma.Ann Surg Oncol 2002; 9:346–54.

    Article  PubMed  Google Scholar 

  35. Robertson JM, Sondak VK, Weiss SA, Sussman JJ, Chang AE, Lawrence TS. Preoperative radiation therapy and iododeoxyuridine for large retroperatoneal sarcomas.Int J Radiat Oncol Biol Phys 1995;31:87–92.

    Article  PubMed  CAS  Google Scholar 

  36. Eilber FR, Eckardt J, Rosen G, Forscher C, Selch MT, Fu YS. Preoperative therapy for soft tissue sarcoma.Hematol Oncol Clin North Am 1995;9:817–23.

    PubMed  CAS  Google Scholar 

  37. Pisters PWT, Patel SR, Pollock RE, et al. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and electron-beam intraoperative radiation therapy (IORT) for resectable retroperitoneal sarcomas [Abstract].Cancer J Sci Am 1998;4:103.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter W. T. Pisters MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pisters, P.W.T., Ballo, M.T. & Patel, S.R. Preoperative chemoradiation treatment strategies for localized sarcoma. Annals of Surgical Oncology 9, 535–542 (2002). https://doi.org/10.1007/BF02573888

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02573888

Key Words

Navigation